Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

RP902

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 3, 2026 · PHASE 2 TRIAL

To Evaluate the Safety and Efficacy of RP902 Tablets

ClinicalTrials.gov

Phase 2 trial of an unapproved investigational drug in MCI with no results yet reported; registration describes planned conduct only.

PreliminaryRisen (Suzhou) Pharma Tech Co.NCT07579884 RP902

Reported

Planned enrollment360

PhasePhase 2

Primary outcome measureClinical Dementia Rating Scale - Sum of Box…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support